AVE receives final ethics approval for Phase III CBD trial Released 06 Mar 24
Latest announcements
Ask a question
Your question will be sent privately to Avecho Biotechnology. The company may choose to make this question public.
Investor Q&A's
Start the conversation
Ask Avecho Biotechnology a question about this announcement.